Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-11-06
2007-11-06
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200, C536S007300, C536S007400
Reexamination Certificate
active
11302529
ABSTRACT:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
REFERENCES:
patent: 5866549 (1999-02-01), Or et al.
patent: 6075011 (2000-06-01), Or et al.
patent: 6740642 (2004-05-01), Angehr et al.
patent: 0 559 896 (1993-09-01), None
patent: WO 93/21200 (1993-10-01), None
patent: WO 97/10251 (1997-03-01), None
patent: WO 00/78773 (2000-12-01), None
patent: WO 03/095466 (2003-11-01), None
patent: WO 03/097659 (2003-11-01), None
U.S. Appl. No. 11/008,581, filed Dec. 7, 2004, Or et al.
U.S. Appl. No. 11/324,502, filed Jan. 2, 2006, Or et al.
U.S. Appl. No. 11/236,043, filed Sep. 27, 2005, Or et al.
U.S. Appl. No. 11/302,525, filed Dec. 13, 2005, Tang et al.
Zhenkun, Ma, et al., “Novel Erythromycin Derivatives With Aryl Groups Tethered to the C-6 Position are Potent Protein Synthesis Inhibitors and Active Against Multidrug-Resistant Respiratory Pathogens,”J. Med. Chem., 44:4137-4156 (2001).
Chen Zhigang
Gai Yonghua
Or Yat Sun
Sun Ying
Tang Datong
Elmore Carolyn S.
Elmore Patent Law Group
Enanta Pharmaceuticals, Inc.
Nakajima Suanne
Peselev Elli
LandOfFree
11,12-lactone bicyclolides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11,12-lactone bicyclolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11,12-lactone bicyclolides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3866564